Gene-environment interactions: A review of effects on reproduction and development

Critical Reviews in Toxicology

Volumn 34, Issue 6, 2004, Pages 461-485

  Cummings, Audrey M ^a   Kavlock, Robert J ^a  

^a U S ENVIRONMENTAL PROTECTION AGENCY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

5,10 METHYLENETETRAHYDROFOLATE REDUCTASE (FADH2); ABAMECTIN; ALCOHOL; ALCOHOL DEHYDROGENASE; ANDROGEN RECEPTOR; ARYLDIALKYLPHOSPHATASE; AVERMECTIN; BENZENE; CIGARETTE SMOKE; CYTOCHROME P450 2E1; DIGOXIN; DIPEPTIDYL CARBOXYPEPTIDASE; FOLIC ACID; GLUTATHIONE TRANSFERASE; GLYCOPROTEIN P; IVERMECTIN; ORGANOPHOSPHATE PESTICIDE; PACLITAXEL; PESTICIDE; SAQUINAVIR; TRANSFORMING GROWTH FACTOR ALPHA; VINCLOZOLIN;

ANENCEPHALUS; ANIMAL MODEL; CIGARETTE SMOKING; CLEFT PALATE; CONGENITAL MALFORMATION; CONTROLLED STUDY; ENVIRONMENTAL EXPOSURE; ENZYME ACTIVITY; FEMALE; FETAL ALCOHOL SYNDROME; FOLATE METABOLISM; GENETIC POLYMORPHISM; GENOTYPE; HUMAN; INFERTILITY; MALE; MALE INFERTILITY; MOUSE; NEURAL TUBE DEFECT; NEUROTOXICITY; NONHUMAN; PREECLAMPSIA; PREGNANCY; PRENATAL DEVELOPMENT; REPRODUCTION; REPRODUCTIVE TOXICITY; REVIEW; SPINA BIFIDA;

ANIMALS; DIET; DISEASE MODELS, ANIMAL; DRUG RESISTANCE, MULTIPLE; ENVIRONMENT; ENVIRONMENTAL HEALTH; EPIDEMIOLOGIC STUDIES; GENETIC PREDISPOSITION TO DISEASE; GROWTH; HUMANS; INFERTILITY; PESTICIDES; POLYMORPHISM, GENETIC; REPRODUCTION; XENOBIOTICS;

ANIMALIA;

EID: 7444229862     PISSN: 10408444     EISSN: None     Source Type: Journal    
DOI: 10.1080/10408440490519786     Document Type: Review

References (176)

1. Cavelli-Sforza, L. L., and Bodmer, W. F. (1971). The Genetics of Human Populations. p. 118. San Francisco: W. H. Freeman.
2. Kerem, B., Rommens, J. M., Buchanan, J. A., Markiewicz, D., Cox, T. K., Chakravarti, A., Buchwald, M., and Tsui, L. C. (1989). Identification of the cystic fibrosis gene: Genetic analysis. Science, 245:1073.
3. Collins, F. S., Brooks, L. D., and Chakravarti, A. (1998). A DNA polymorphism discovery resource for research on human genetic variation. Genome Res. 8:1229.
4. Ottman, R. (1996). Gene-environment interaction: Definitions and study designs. Prev. Med. 25:764.
5. Vineis, P. (2002). The relationship between polymorphisms of xenobiotic metabolizing enzymes and susceptibility to cancer. Toxicology 181-182:457.
6. Mucci, L. A., Wedren, S., Tamimi, R. M., Trichopoulos, D., and Adami, H. O. (2001). The role of gene-environment interaction in the aetiology of human cancer: Examples from cancers of the large bowel, lung and breast. J. Intern. Med. 249:477.
7. Talmud, P. J., Hawe, E., and Miller, G. J. (2002). Analysis of gene-environment interaction in coronary artery disease: Lipoprotein lipase and smoking as examples. Ital. Heart J. 3:6.
8. Cortese, C., and Motti, C. (2001). MTHFR gene polymorphism, homocysteine and cardiovascular disease. Public Health Nutr. 4:493.
9. Brown, P. O., and Hartwell, L. (1998). Genomics and human disease-Variations on variation. Nat. Genet. 18:91.
10. Barron, W. M. (1992). The syndrome of preeclampsia. Gastroenterol. Clin. North Am. 21:851.
11. Kim, Y. J., Williamson, R. A., Chen, K., Smith, J. L., Murray, J. C., and Merrill, D. C. (2001). Lipoprotein lipase gene mutations and the genetic susceptibility of preeclampsia. Hypertension 38:992.
12. Witt, C. S., Whiteway, J. M., Warren, H. S., Barden, A., Rogers, M., Martin, A., Beilin, L., and Christiansen, F. T. (2002). Alleles of the KIR2DL4 receptor and their lack of association with pre-eclampsia. Eur. J. Immunol. 32:18.
13. Liao, W.-X., and Roy, A. C. (2002). Lack of association between polymorphisms in the testis-specific angiotensin converting enzyme gene and male infertility in an Asian population. Mol. Hum. Reprod. 8:299.
14. Orioli, I. M., Vieira, A. R., Castilla, E. E., Ming, J. E., and Muenke, M. (2002). Mutational analysis of the Sonic Hedgehog gene in 220 newborns with oral clefts in a South American (ECLAMC) population. Am. J. Med. Genet. 108:12.
15. Leveille-Webster, C. R., and Arias, I. M. (1995). The biology of the P-glycoproteins. J. Membr. Biol. 143:89.
16. Chin, J. E., Soffir, R., Noonan, K. E., Choi, K., and Roninson, I. B. (1989). Structure and expression of the human MDR (P-glycoprotein) gene family. Mol. Cell Biol. 9:3808.
17. Croop, J. M., Raymond, M., Haber, D., Devault, A., Arceci, R. J., Gros, P., and Housman, D. (1989). The three mouse multidrug resistance (mdr) genes are expressed in a tissue-specific manner in normal mouse tissues. Mol. Cell Biol. 9:1346.
18. Schinkel, A. H., Smit, J. J., van Tellingen, O., Beijnen, J. H., Wagenaar, E., van Deemter, L., Mol, C. A., van der Valk, M. A., Robanus-Maandag, E. C., te Riele, H. P., Berns, A. J., and Borst, P. (1994). Disruption of the mouse mdr1a P-glycoprotein gene leads to a deficiency in the blood-brain barrier and to increased sensitivity to drugs. Cell 77:491.
19. Cordon-Cardo, C., O'Brien, J. P., Casals, D., Rittman-Grauer, L., Biedler, J. L., Melamed, M. R., and Bertino, J. R. (1989). Multidrug-resistance gene (P-glycoprotein) is expressed by endothelial cells at blood-brain barrier sites. Proc. Natl. Acad. Sci. USA 86:695.
20. Thiebaut, F., Tsuruo, T., Hamada, H., Gottesman, M., Pastan, I., and Willingham, M. C. (1987). Cellular localization of the multidrug resistance gene product in normal human tissues. Proc. Natl. Acad. Sci. USA 84:7735.
21. Umbenhauer, D., Lankas, G. R., Pippert, T., Wise, L. D., Cartwright, M. E., Hall, S. J., and Beare, C. M. (1997). Identification of a P-glycoprotein-deficient subpopulation in the CF-1 mouse strain using a restriction fragment length polymorphism. Toxicol. Appl. Pharmacol. 146:88.
22. Lankas, G. R., Wise, L. D., Cartwright, M. E., Pippert, T., and Umbenhauer, D. (1998). Placental P-glycoprotein deficiency enhances susceptibility to chemically induced birth defects in mice. Reprod. Toxicol. 12:457.
23. Arceci, R. J., Croop, J. M., Horwitz, S. B., and Housman, D. (1988). The gene encoding multidrug resistance is induced and expressed at high levels during pregnancy in the secretory epithelium of the uterus. Proc. Natl. Acad. Sci. USA 85:4350.
24. Smit, J. W., Huisman, M. T., van Tellingen, O., Wiltshire, H. R., and Schinkel, A. H. (1999). Absence or pharmacological blocking of placental P-glycoprotein profoundly increases fetal drug exposure. J. Clin. Invest. 104:1441.
25. Cagen, S. Z., Waechter, J. M., Dimond, S. S., Breslin, W. J., Butala, J. H., Jekat, F. W., Joiner, R. L., Shiotsuka, R. N., Veenstra. G. E., and Harris, L. R. (1999). Normal reproductive organ development in CF-1 mice following prenatal exposure to bisphenol A. Toxicol. Sci. 50:36.
26. MacFarland, A., Abramovich, D. R., Ewen, S. W., and Pearson. C. K. (1994). Stage-specific distribution of P-glycoprotein in first-trimester and full-term human placenta. Histochem. J. 26:417.
27. Nakamura, Y., Ikeda, S., Furukawa, T., Sumizawa, T., Tani, A., Akiyama, S., and Nagata, Y. (1997). Function of P-glycoprotein expressed in placenta and mole. Biochem. Biophys. Res. Commun. 235:849.
28. Czeizel, A. E., and Dudas, I. (1992). Prevention of the first occurrence of neural tube defects by periconceptual vitamin supplementation. N. Engl. J. Med. 327:1832.
29. Laurence, K. M., James, N., Miller, M., Tennant, G. B., and Campbell, H. (1981). Double-blind randomised controlled trial of folate treatment before conception to prevent recurrence of neural-tube defects. Br Med. J. 282:1509.
30. Smithells, R. W., Nevin, N. C., Seller, M. J., Sheppard, S., Harris, R., Read, A. P., Fielding, D. W., Walker, S., Schorah, C. J., and Wild, J. (1983). Further experience of vitamin supplementation for prevention of neural tube defect recurrences. Lancet 1:1027.
31. Kirke, P. N., Daly, L. E., and Elwood, J. H. (1920). A randomised trial of low dose folic acid to prevent neural tube defects. Arch. Dis. Child. 67:1442.
32. Williams, L. J., Mai, C. T., Edmonds, L. D., Shaw, G. M., Kirby, R. S., Hobbs, C., Sever, L. E., Miller, L. A., Meaney, F. J., and Levitt, M. (2002). Prevalence of spina bifida and anencephaly during the transition to mandatory folic acid fortification in the United States. Teratology 66:33.
33. Fodinger, M., Horl, W. H., and Sunder-Plassmann, G. (2000). Molecular biology of 5,10-methylenetetrahydrofolate reductase. J. Nephrol. 13:20.
34. Whitehead, A. S., Gallagher, P., Mills, J. L., Kirke, P. N., Burke, H., Molloy, A. M., Weir, D. G., Shields, D. C., and Scott, J. M. (1995). A genetic defect in 5,10-methylenetetrahydrofolate reductase in neural tube defects. Q. J. Med. 88:763.
35. van der Put, N. M. J., and Blom, H. J. (2000). Neural tube defects and a disturbed folate dependent homocysteine metabolism. Eur. J. Obstet. Gyn. Res. Bull. 92:57.
36. Daly, L. E., Kirke, P. N., Molloy, A. M., Weir, D. G., and Scott, J. M. (1995). Folate levels and neural tube defects: Implications for prevention. J. Am. Med. Assoc. 274:1698.
37. Moyers, S., and Bailey, L. B. (2001). Fetal malformations and folate metabolism: Review of recent evidence. Nutr. Res. 59:215.
38. Botto, L. D., and Yang, Q. (2000). 5,10-Methylenetetrahydrofolate reductase gene variants and congenital anomalies: A HuGE review. Am. J. Epidemiol. 151:862.
39. van der Put, N., Steegers-Theunissen, R. P., Frosst, P., Trijbels, F. J., Eskes, T. K., van den Heuvel, L. P., Mariman, E. C., den Heyer, M., Rozen, R., and Blom, H. J. (1995). Mutated methylenetetrahydrofolate reductase as a risk factor for spina bifida. Lancet 346:1070.
40. van der Put, N., Gabreels, F. J., Stevens, E., Smeitink, J. A., Trijbels, F. J., Eskes, T. K., van den Heuvel, L. P., and Blom, H. J. (1998). A second common mutation in the methylenetetrahydrofolate reductase gene: An additional risk factor for neural tube defects? Am. J. Hum. Genet. 62:1044.
41. Shaw, G. M., Rozen, R., Finnell, R. H., Wasserman, C. R., and Lammer, E. J. (1998). Maternal vitamin use, genetic variation of infant methylenetetrahydrofolate reductase, and risk for spina bifida. Am. J. Epidemiol. 148:30.
42. Kirke, P. N., Mills, J. L., Whitehead, A. S., Molloy, A. M., and Scott, J. M. (1996). Methylenetetrahydrofolate reductase mutation and neural tube defects. Lancet 348:1037.
43. Ou, C. Y., Stevenson, R. E., Brown, V. K., Schwartz, C. E., Allen, W. P., Khoury, M. J., Rozen, R., Oakley, G. P., and Adams, M. J. (1996). 5,10-methylenetetrahydrofolate reductase genetic polymorphism as a risk factor for neural tube defects. Am. J. Med. Genet. 63:610.
44. Molloy, A. M., Mills, J. L., Kirke, P. N., Ramsbottom, D., Mcpartlin, J. M., Burke, H., Conley, M. R., Whitehead, A. S., Weir, D. G., and Scott, J. M. (1998). Low blood folates in NTD pregnancies are only partly explained by thermolabile methylenetetrahydrofolate reductase: Low folate status alone may be the critical factor. Am. J. Genet. 78:155.
45. Papapetrou, C., Lynch, S. A., Burn, J., and Edwards, Y. H. (1996). Methylenetetrahydrofolate reductase and neural tube defects. Lancet 348:58.
46. Mornet, E., Muller, F., Lenvoise-Furet, A., Delezoide, A.-L., Col, J. Y., Simon-Bouy, B., and Serre, J. L. (1997). Screening of the C677T mutation on the methylenetetrahydrofolate reductase gene in French patients with neural tube defects. Hum. Genet. 100:512.
47. Shaw, G. M., Rozen, R., Finnell, R. H., Todoroff, K., and Lammer, E. J. (1998). Infant C677T mutation in MTHFR, maternal periconceptional vitamin use, and cleft lip. Am. J. Med. Genet. 80:196.
48. Mills, J. L., Kirke, P. N., Molloy, A. M., Burke, H., Conley, M. R., Lee, Y. J., Mayne, P. D., Weir, D. G., and Scott, J. M. (1999). Methylenetetrahydrofolate reductase thermolabile variant and oral clefts. Am. J. Med. Genet. 86:71.
49. James, S. J., Pogribna, M., Pogribny, I. P., Melnyk, S., Hine, R. J., Gibson, J. B., Yi, P., Tafoya, D. L., Swenson, D. H., Wilson, V. L., and Gaylor, D. W. (1999). Abnormal folate metabolism and mutation in the methylenetetrahydrofolate reductase gene may be maternal risk factors for Down syndrome. Am. J. Clin. Nutr. 70:495.
50. Hobbs, C., Sherman, S. L., Yi, P., Hopkins, S. E., Torfs, C. P., Hine, R. J., Pogribna, M., Rozen, R., and James, S. J. (2000). Polymorphisms in genes involved in folate metabolism as maternal risk factors for Down syndrome. Am. J. Hum. Genet. 67:623.
51. MRC Vitamin Study Research Group. (1991). Prevention of neural tube defects: Results of the Medical Research Council vitamin study. Lancet 338:131.
52. Christensen, B., Arbour, L., Tran, P., Leclerc, D., Sabbaghian, N., Platt, R., Gilfix, B. M., Rosenblatt, D. S., Gravel, R. A., Forbes, P., and Rozen, R. (1999). Genetic polymorphisms in methylenetetrahydrofolate reductase and methionine synthase, folate levels in red blood cells, and risk of neural tube defects. Am. J. Med. Genet. 84:151.
53. Rosenquist, T. H., Ratashak, S. A., and Selhub, J. (1996). Homocysteine induces congenital defects of the heart and neural tube: Effect of folic acid. Proc. Natl. Acad. Sci. USA 93:15227.
54. Iamaroon, A., Tait, B., and Diewert, V. M. (1996). Cell proliferation and expression of EGF, TGF alpha, and EGF receptor in the developing primary palate. J. Dent. Res. 75:1534.
55. Dixon, M. J., Garner, J., and Ferguson, M. W. (1991). Immunolocalization of epidermal growth factor (EGF), EGF receptor and transforming growth factor alpha (TGF alpha) during murine palatogenesis in vivo and in vitro. Anat. Embryol. 184:83.
56. Machida, J., Yoshiura, K., Funkhauser, C. D., Natsume, N., Kawai, T., and Murray, J. C. (1999). Transforming growth factor-alpha (TGFA): Genomic structure, boundary sequences, and mutation analysis in nonsyndromic cleft lip/palate and cleft palate only. Genomics 61:237.
57. Jara, L., Blanco, R., Chiffelle, I., Palomino, H., and Carreno, H. (1995). Association between alleles of the transforming growth factor alpha locus and cleft lip and palate in the Chilean population. Am. J. Med. Genet. 57:548.
58. Feng, H., Sassani, R., Bartlett, S. P., Lee, A., Hecht, J. T., Malcom, S., Winter, R. M. W., Vintiner, G. M., Buetow, K. H., and Gasser, D. L. (1994). Evidence, from family studies, for linkage disequilibrium between TGFA and a gene for nonsyndromic cleft lip with or without cleft palate. Am. J. Hum. Genet. 55:932.
59. Lidral, A. C., Romitti, P. A., Basart, A. M., Doetschman, T., Leysens, N. J., Daack-Hirsch, S., Semina, E. V., Johnson, L. R., Machida, J., Burds, A., Parnell, T. J., Rubenstein, J. L. R., and Murray, J. C. (1998). Association of MSX 1 and TGFB3 with non-syndromic clefting in humans. Am. J. Hum. Genet. 63:557.
60. Field, L. L., Ray, A. K., and Marazita, M. L. (1994). Transforming growth factor alpha: A modifying locus for nonsyndromic cleft lip with or without cleft palate? Eur. J. Hum. Genet. 2:159.
61. Scapoli, L., Pezzetti, F., Carinci, F., Martinelli, M., Carinci, P., and Tognon, M. (1998). Lack of linkage disequilibrium between transforming growth factor alpha Taq 1 polymorphism and cleft lip with or without cleft palate in families from Northeastern Italy. Am. J. Med. Genet. 75:203.
62. Mitchell, L. E. (1997). Transforming growth factor alpha locus and nonsyndromic cleft lip with or without cleft palate: A reappraisal. Genet. Epidemiol. 14:231.
63. Kallen, K. (1997). Maternal smoking and orofacial clefts. Cleft Palate-Cran. J. 34:11.
64. Lorente, C., Cordier, S., Goujard, J., Segolene, A., Bianchi, F., Calzolari, E., De Walle, H. E. K., Knill-Jones, R., and Occupational Exposure and Congenital Malformations Working Group. (2000). Tobacco and alcohol use during pregnancy and risk of oral clefts. Am. J. Public Health 90:415.
65. Chung, K. C., Kowalski, C. P., Kim, H. M., and Buchman, S. R. (2000). Maternal cigarette smoking during pregnancy and the risk of having a child with cleft lip/palate. Plast. Reconstr. Surg. 105:485.
66. Khoury, M. J., Weinstein. A., Panny, S., Holtzman, N. A., Lindsay, P. K., Farrel, K., and Eisenberg, M. (1987). Maternal cigarette smoking and oral clefts: A population-based study. Am. J. Public Health 77:623.
67. Werler, M. M., Lammer, E. J., Rosenberg, L., and Mitchell, A. A. (1990). Maternal cigarette smoking during pregnancy in relation to oral clefts. Am. J. Epidemiol. 132:926.
68. Lieff, S., Olshan, A. F., Werler, M. M., Strauss, R. P., Smith, J., and Mitchell, A. A. (1999). Maternal cigarette smoking during pregnancy and risk of oral clefts in newborns. Am. J. Epidemiol. 150:683.
69. Wyszynski, D. F., Duffy, D. L., and Beaty, T. H. (1997). Maternal cigarette smoking and oral clefts: A meta-analysis. Cleft Palate-Cran. J. 34:206.
70. Hwang, S.-J., Beaty, T. H., Panny, S. R., Street, N. A., Joseph, J. M., Gordon, S., McIntosh, I., and Francomano, C. A. (1995). Association study of transforming growth factor alpha (TGFalpha) Taq1 polymorphism and oral clefts: Indication of gene-environment interaction in a population-based sample of infants with birth defects. Am. J. Epidemiol. 141:629.
71. Shaw, G. M., Wasserman, C. R., Lammer. E. J., O'Malley, C. D., Murray, J. C., Basart, A. M., and Tolarova, M. M. (1996). Orofacial clefts, parental cigarette smoking, and transforming growth factor-alpha gene variants. Am. J. Hum. Genet. 58:551.
72. Maestri, N. E., Beaty, T. H., Hetmanski, J., Smith, E. A., McIntosh, I., Wyszynski, D. F., Liang, K.-Y., Duffy, D. L., and VanderKolk. C. (1997). Application of transmission disequilibrium tests to nonsyndromic oral clefts Am. J. Med. Genet. 73:337.
73. Romitti, P. A., Lidral. A. C., Munger, R. G., Daack-Hirsch, S., Burns, T. L., and Murray, J. C. (1999). Candidate genes for nonsyndromic cleft lip and palate and maternal cigarette smoking and alcohol consumption: Evaluation of genotype-environment interactions from a population-based case-control study of orofacial clefts. Teratology 59:39.
74. van Rooij, I. A., Wegerif, M., Roelofs, H., Peters, W. H., Kuijpers-Jagtman, A.-M., Zielhuis, G. A., Merkus, H. M., and Steegers-Theunissen, R. P. (2001). Smoking, genetic polymorphisms in biotransformation enzymes, and nonsyndromic oral clefting: A gene-environment interaction. Epidemiology 12:502.
75. Christensen, K., Olsen, J., Norgaard-Pedersen, B., Basso, O., Stovring, H., Milhollin-Johnson, L., and Murray, J. C. (1999). Oral clefts, transforming growth factor alpha gene variants, and maternal smoking: A population-based case control study in Denmark, 1991-1994. Am. J. Epidemiol. 149:248.
76. Fitzpatrick, D. R., Denhez, F., Kondaiah, P., and Akhurst, R. J. (1990). Differential expression of TGF beta isoforms in murine palatogenesis. Development 109:585.
77. Abbott, B. D., Probst, M. R., Perdew, G. H., and Buckalew, A. R. (1998). AH receptor, ARNT, glucocorticoid receptor, EGF receptor, EGF, TGF alpha, TGF beta 1, TGF beta 2, and TGF beta 3 expression in human embryonic palate, and effects of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD). Teratology 58:30.
78. Clarren, S. K., and Smith, D. W. (1978). The fetal alcohol syndrome. N. Engl. J. Med. 298:1063.
79. Chernoff, G. F. (1980). The fetal alcohol syndrome in mice: Maternal variables. Teratology 22:71.
80. Agarwal, D. P. (2001). Genetic polymorphisms of alcohol metabolizing enzymes. Pathol. Biol. 49:703.
81. Bosron, W. F., and Li, T.-K. (1986). Genetic polymorphism of human liver alcohol and aldehyde dehydrogenases, and their relationship to alcohol metabolism and alcoholism. Hepatology 6:502.
82. McCarver, D. G., Byun, R., Hines, R., Hichme, M., and Wegenek, W. (1998). A genetic polymorphism in the regulatory sequences of human CYP2E1: Association with increased chlorzoxone hydroxylation in the presence of obesity and ethanol intake. Toxicol. Appl. Pharmacol. 152:276.
83. McCarver. D. G. (2001). ADH2 and CYP2E1 genetic polymorphisms: Risk factors for alcohol-related birth defects. Drug Metab. Dispos. 29:562.
84. Bosron, W. F., and Li, T.-K. (1987). Catalytic properties of human liver alcohol dehydrogenase isoenzymes. Enzyme 37:19.
85. Jornvall, H., and Hoog, J.-O. (1995). Nomenclature of alcohol dehydrogenases. Alcohol Alcoholism 30:153.
86. McCarver, D. G., Thomasson, H. R., Martier, S. S., Sokol, R. J., and Li, T.-K. (1997). Alcohol dehydrogenase-2*3 allele protects against alcohol related birth defects among African Americans. J Pharmacol. Exp. Ther. 283:1095.
87. Bonthius, D. J., Goodlett, C. R., and West, J. R. (1988). Blood alcohol concentration and severity of microencephaly in neonatal rats depend on the pattern of alcohol administration. Alcohol 5:209.
88. Thomasson, H. R., Beard, J. D., and Li, T.-K. (1995). ADH2 gene polymorphisms are determinants of alcohol pharmacokinetics. Alcohol Clin. Exp. Res. 19:1494.
89. Sokol, R. J., Ager, J., Martier, S. S., Debanne, S., Ernhart, C., Kuzma, J., and Miller, S. (1986). Significant determinants of susceptibility to alcohol teratogenicity. Ann. NY Acad. Sci. 477:87.
90. Hard, M. L., Einarson, T. R., and Koren, G. (2001). The role of acetaldehyde in pregnancy outcome after prenatal alcohol exposure. Ther. Drug Monit. 23:427.
91. Hu, Y., Oscarson, M., Johansson, I., Yue, Q.-Y., Dahl, M.-L., Tabone, M., Arinco, S., Albano, E., and Ingelman-Sundberg, M. (1997). Genetic polymorphism of human CYP2E1: Characterization of two variant alleles. Mol. Pharmacol. 51:370.
92. Rasheed, A., Hines, R., and McCarver-May, D. G. (1997). Variation in induction of human placental CYP2E1: Possible role in susceptibility to fetal alcohol syndrome? Toxicol. Appl. Pharmacol. 144:396.
93. Ingram, J. L., Stodgell, C. J., Hyman, S. L., Figlewicz, D. A., Weitkamp, L. R., and Rodier, P. M. (2000). Discovery of allelic variants of HOXA1 and HOXB1: Genetic susceptibility to autism spectrum disorders. Teratology 62:393.
94. Wubah, J. A., Ibrahim, M. M., Gao, X., Nguyen, D., Pisano, M. M., and Knudsen, T. B. (1996). Teratogen-induced eye defects mediated by p53-dependent apoptosis. Curr. Biol. 6:60.
95. Nicol, C. J., Harrison, M. L., Laposa, R. R., Gimelshtein, I. L., and Wells, P. G. (1995). A teratologic suppressor role for p53 in benzo[a]pyrene-treated transgenic p53-deficient mice. Nat. Genet. 10:181.
96. Norimura, T., Nomoto, S., Katsuki, M., Gondo, Y., and Kondo, S. (1996). p53-dependent apoptosis suppresses radiation-induced teratogenesis. Nat. Med. 2:577.
97. Schuppe, H.-C., Wieneke, P., Donat, S., Fritsche, E., Kohn, F.-M., and Abel, J. (2000). Xenobiotic metabolism, genetic polymorphisms and male infertility. Andrologia 32:255.
98. Humbert, R., Adler, D. A., Disteche, C. M., Hassett, C., Omiecinski, C. J., and Furlong, C. E. (1993). The molecular basis of the human serum paraoxonase activity polymorphism. Nat. Genet. 3:73.
99. Li, W.-F., Mathews C., Disteche, C. M., Costa, L. G., and Furlong, C. E. (1997). Paraoxonase (PON 1) gene in mice: Sequencing, chromosomal localization and developmental expression. Pharmacogenetics 7:137.
100. Playfer, J. R., Eze, L. C., Bullen, M. F., and Evans, D. A. P. (1976). Genetic polymorphism and interethnic variability of plasma paroxonase activity. J. Med. Genet. 13:337.
101. Mathew, G., Vijayalaxmi, K. K., and Abdul Rahiman, M. (1992). Methyl parathion-induced sperm shape abnormalities in mouse. Mutat. Res. 280:169.
102. Abd El-Aziz, M. I., Sahlab, A. M., and Abd El-Khalik, M. (1994). Influence of diazinon and deltamethrine on reproductive organs and fertility of male rats. Deut. Tierarztl. Wochensch 101:230.
103. Chou, K. C., and Cook, R. M. (1994). Paraoxon inhibits fertilization of mouse gametes in vitro. Bull. Environ. Contam. Toxicol. 53:863.
104. Padungtod, C., Lasley, B. L., Christiani, D. C., Ryan, L. M., and Xu, X. (1998). Reproductive hormone profile among pesticide factory workers. J. Occup. Environ. Med. 40:1038.
105. Padungtod, C., Niu, T., Wang, Z., Savitz, D. A., Christiani, D. C., Ryan, L. M., and Xu, X. (1999). Paraoxonase polymorphism and its effect on male reproductive outcomes among Chinese pesticide factory workers. Am. J. Ind. Med. 36:379.
106. Padungtod, C., Hassold, T. J., Millie, E., Ryan, L. M., Savitz, D. A., Christiani, D. C., and Xu, X. (1999). Sperm aneuploidy among Chinese pesticide factory workers: Scoring by the FISH method. Am. J. Ind. Med. 36:230.
107. Padungtod, C., Savitz, D. A., Overstreet, J. W., Christiani, D. C., Ryan, L. M., and Xu, X. (2000). Occupational pesticide exposure and semen quality among chinese workers. J. Occup. Environ. Med. 42:982.
108. McKenna, N. J., Lanz, R. B., and O'Malley, B. W. (1999). Nuclear receptor coregulators: Cellular and molecular biology. Endocr Rev. 20:321.
109. Brinkmann, A. O., and Trapman, J. (2000). Genetic analysis of androgen receptors in development and disease. Adv. Pharmacol. 47:317.
110. Loy, C. J., and Yong, E. L. (2001). Sex, infertility and the molecular biology of the androgen receptor. Curr. Opin. Obstet. Gyn. 13:315.
111. Tut, T. G., Ghadessy, F. J., Trifiro, M., Pinsky, L., and Yong, E. L. (1997). Long polyglutamine tracts in the androgen receptor are associated with reduced trans-activation, impaired sperm production, and male infertility. J. Clin. Endocr. Metab. 82:3777.
112. Dowsing, A. T., Yong, E. L., Clark, M., McLachlan, R. I., de Kretser, D. M., and Trounson, A. O. (1999). Linkage between male infertility and trinucleotide repeat expansion in the androgen receptor gene. Lancet 354:640.
113. Legius, E., Vanderschueren, D., Spiessens, C., D'Hooghe, T., and Matthijs, G. (1999). Association between CAG repeat number in the androgen receptor and male infertility in a Belgian study. Clin. Genet. 56:166.
114. Yoshida, K.-I., Yano, M., Chiba, K., Honda, M., and Kitahara, S. (1999). CAG repeat length in the androgen receptor gene is enhanced in patients with idiopathic azoospermia. Urology 54:1078.
115. Patrizio, P., Leonard, D. G. B., Chen, K.-L., Hernandez-Ayup, S., and Trounson, A. O. (2001). Larger trinucleotide repeat size in the androgen receptor gene of infertile men with extremely severe oligozoospermia. J. Androl. 22:444.
116. von Eckardstein, S., Syska, A., Gromoll, J., Kamischke, A., Simoni, M., and Nieschlag, E. (2001). Inverse correlation between sperm concentration and number of androgen receptor CAG repeats in normal men. J. Clin. Endocr. Metab. 86:2585.
117. Wallerand, H., Remy-Martin, A., Chabannes, E., Bermont, L., Adessi, G.-L., and Bittard, H. (2001). Relationship between expansion of the CAG repeat in exon I of the androgen receptor gene and idiopathic male infertility. Fertil. Steril. 76:769.
118. Mifsud, A., Sim, C. K. S., Boettger-Tong, H., Moreira, S., Lamb, D. J., Lipshultz, L. I., and Yong, E. L. (2001). Trinucleotide (CAG) repeat polymorphisms in the androgen receptor gene: Molecular markers of risk for male infertility. Fertil. Steril. 75:275.
119. Giwercman, Y. L., Xu, C., Arver, S., Pousette, A., and Reneland, R. (1998). No association between the androgen receptor gene CAG repeat and impaired sperm production in Swedish men. Clin. Genet. 54:435.
120. Dadze, S., Wieland, C., Jakubiczka, S., Funke, K., Schroder, E., Royer-Pokora, B., Willers. R., and Wieacker, P. F. (2000). The size of the CAG repeat in exon 1 of the androgen receptor gene shows no significant relationship to impaired spermatogenesis in an infertile Caucasoid sample of German origin. Mol. Hum. Reprod. 6:207.
121. Sasagawa, I., Suzuki, Y., Ashida, J., Nakada, T., Muroya, K., and Ogata, T. (2001). CAG repeat length analysis and mutation screening of the androgen receptor gene in Japanese men with idiopathic azoospermia. J. Androl. 22:804.
122. Irvine, R., Yu, M. C., Ross, R. K., and Coetzee, G. (1995). The CAG and GGC microsatellites of the androgen receptor are in linkage disequilibrium in men with prostate cancer. Cancer Res. 55:1937.
123. La Spada, A. R., Wilson, E. M., Lubahn, D. B., Harding, A. E., and Fischbeck, K. H. (1991). Androgen receptor gene mutations in X-linked spinal and bulbar muscular atrophy. Nature 352:77.
124. Chamberlain, N. L., Driver, E. D., and Miesfeld, R. L. (1994). The length and location of CAG trinucleotide repeats in the androgen receptor N-terminal domain affect transactivation function. Nucleic Acids Res. 22:3181.
125. Choong, C. S., Kemppainen, J. A., Zhou, Z., and Wilson, E. M. (1996). Reduced androgen receptor gene expression with first exon CAG repeat expansion. Mol. Endocrinol. 10:1527.
126. Irvine, R., Ma, H., Yu, M. C., Ross, R. K., Stallcup, M. R., and Coetzee, G. (2000). Inhibition of p160-mediated coactivation with increasing androgen receptor polyglutamine length. Hum. Mol. Genet. 9:267.
127. Shimohata, T., Nakajima, T., Yamada, M., Uchida, C., Onodera, O., Naruse, S., Kimura, T., Koide, R., Nozaki, K., Sano, Y., Ishiguro, H., Sakoe, K., Ooshima, T., Sato, A., Ikeuchi, T., Oyake, M., Sato, T., Aoyagi, Y., Hozumi, I., Nagatsu, T., Takiyama, Y., Nishizawa, M., Goto, J., Kanasawa, I., Davidson, I., Tanese, N., Takahashi, H., and Tsuji, S. (2000). Expanded polyglutamine stretches interact with TAFIII30, interfering with CREB-dependent transcription. Nat. Genet. 26:29.
128. Muroya, K., Sasagawa, I., Suzuki, Y., Nakada, T., Ishii, T., and Ogata, T. (2001). Hypospadias and the androgen receptor gene: Mutation screening and CAG repeat length analysis. Mol. Hum. Reprod. 7:409.
129. Ishii, T., Sato, S., Kosaki, K., Sasaki, G., Muroya, K., Ogata, T., and Matsuo, N. (2001). Micropenis and the AR gene: Mutation and CAG repeat-length analysis. J. Clin. Endocr. Metab. 86:5372.
130. Schoenberg, M. P., Hakimi, J. M., Wang, S., Bova, G. S., Epstein, J. I., Fischbeck, K. H., Isaacs, W. B., Walsh, P. C., and Barrack, E. R. (1994). Microsatellite mutation (CAG24→18) in the androgen receptor gene in human prostate cancer. Biochem. Biophys. Res. Commun. 198:74.
131. Green, J. M., Ballou, D. P., and Matthews, R. G. (1988). Examination of the role of methylenetetrahydrofolate reductase in incorporation of methyltetrahydrofolate into cellular metabolism. FASEB J. 2:42.
132. Bailey, L. B., and Gregory, J. F. (1999). Polymorphisms of methylenetetrahydrofolate reductase and other enzymes: Metabolic significance, risks and impact on folate requirement. J. Nutr. 129:919.
133. Rosenberg, I. H., and Rosenberg, L. E. (1998). The implications of genetic diversity for the nutrient requirements: The case of folate. Nutr. Rev. 56:S47.
134. Perry, I. J., Refsum, H., Morris, R. W., Ebrahim, S. B., Ueland, P. M., and Shaper, A. C. (1995). Prospective study of serum total homocysteine concentrations and risk of stroke in middle aged British men. Lancet 346:1395.
135. Petri, M., Roubenhoff, R., Dallal, G. E., Nadeau, M. R., Selhub, J., and Rosenberg, I. H. (1996). Plasma homocysteine as a risk factor for atherothrombotic events in systematic lupus erythematosus. Lancet 348:1120.
136. Malinow, M. R., Nieto, F. J., Szklo, M., Chambless, L. E., and Bond, G. (1993). Carotid artery intimal-medial thickening and plasma homocysteine in asymptomatic adults: The Atherosclerosis Risk in Communities Study. Circulation 87, 1107.
137. Selhub, J., Jacques, P. F., Boston, A. G., D'Agostino, R. B., Wilson, P. W., Belanger, A. J., O'Leary, D. H., Wolf, P. A., Schaefer, E. J., and Rosenberg, I. H. (1995). Association between plasma homocysteine concentration and extracranial carotid-artery stenosis. N. Engl. J. Med. 332:286.
138. Robillard, P. Y. (2002). Interest in preeclampsia for researchers in reproduction. J. Reprod. Immunol. 53:279.
139. Isler, C. M., and Martin, J. N., Jr. (2002) Preeclampsia: Pathophysiology and practice considerations for the consulting nephrologist. Semin. Nephrol. 22:54.
140. Redman, C. W., and Sargent, I. L. (2001). The pathogenesis of pre-eclampsia. Gynecol. Obstet. Fertil. 29:518.
141. Harger, J. H., Archer, D. F., Marchese, S. G., Muracca-Clemens, M., and Garver, K. (1983). Etiology of recurrent pregnancy losses and outcome of subsequent pregnancies. Obstet. Gynecol. 62:574.
142. Dlugosz, L., Belanger, K., Hellenbrand, K., Holford, T., Leaderer, B., and Bracken, M. B. (1996). Maternal caffeine consumption and spontaneous abortion: A prospective cohort study. Epidemiology 7:250.
143. Cummings, A. M. (1990). Toxicological mechanisms of implantation failure. Fundam. Appl. Toxicol. 15:571.
144. Kupfermine, M. J., Eldor, A., Steinman, N., Many, A., Bar-Am, A., Jaffa, A., Fait, G., and Lessing, J. B. (1999). Increased frequency of genetic thrombophilia in women with complications of pregnancy. N. Engl. J. Med. 340:9.
145. Grandone, E., Margaglione, M., Colaizzo, D., Cappucci, G., Paladini, D., Martinelli, P., Montanaro, S., Pavone, G., and Di Minno, G. (1997). Factor V Leiden, C→T MTHFR polymorphism and genetic susceptibility to preeclampsia. Thromb. Haemostasis 77:1052.
146. Sohda, S., Arinami, T., Hamada, H., Yamada, Hamaguchi, H., and Kubo, T. (1997). Methylenetetrahydrofolate reductase polymorphism and preeclampsia. J. Med. Genet. 34:525.
147. Van der Molen, E. F., Arends, G. E., Nelen, W. L., van der Put, N. J., Heil, S. G., Eskes, T. K., and Blom, H. J. (2000). A common mutation in the 5,10-methylenetetrahydrofolate reductase gene as a new risk factor for placental vasculopathy. Am. J. Obstet. Gynecol. 182:1258.
148. Zusterzeel, P. L., Visser, W., Blom, H. J., Peters, W. H., Heil, S. G., and Steegers, E. A. (2000). Methylenetetrahydrofolate reductase polymorphisms in preeclampsia and the HELLP syndrome. Hypertens. Pregnancy 19:299.
149. Kim, Y. J., Williamson, R. A., Murray, J. C., Andrews, J., Pietscher. J. J., Peraud, P. J., and Merrill, D. C. (2001). Genetic susceptibility to preeclampsia: Roles of cytosine-to-thymine substitution at nucleotide 677 of the gene for methylenetetrahydrofolate reductase, 68-base pair insertion at nucleotide 844 of the gene for cystathionine beta-synthase, and factor V Leiden mutation. Am. J. Obstet. Gynecol. 184:1211.
150. Prasmusinto, D., Skrablin, S., Hofstaetter, C., Fimmers, R., and van der Ven, K. (2002). The methylenetetrahydrofolate reductase 677 C→T polymorphism and preeclampsia in two populations. Obstet. Gynecol. 99:1085.
151. Rajkovic, A., Mahomed, K., Rozen, R., Malinow, M. R., King, I. B., and Williams, M. A. (2000). Methylenetetrahydrofolate reductase 677 C→T polymorphism, plasma folate, vitamin B(12) concentrations, and risk of preeclampsia among black African women from Zimbabwe. Mol. Genet. Metab. 69:33.
152. Kobashi, G., Yamada, H., Asano, T., Nagano, S., Hata, A., Kishi, R., Fujimoto, S., and Kondo, K. (2000). Absence of association between a common mutation in the methylenetetrahydrofolate reductase gene and preeclampsia in Japanese women. Am. J. Med. Genet. 93:122.
153. Powers, R. W., Minich, L. A., Lykins, D. L., Ness, R. B., Crombleholme, W. R., and Roberts, J. (1999). Methylenetetrahydrofolate reductase polymorphism, folate, and susceptibility to preeclampsia. J. Soc. Gynecol. Invest. 6:74.
154. Nelen, W. L., Steegers, E. A., Eskes, T. K., and Blom, H. J. (1997). Genetic risk factor for unexplained recurrent early pregnancy loss. Lancet 350:861.
155. Nelen, W. L., Blom, H. J., Steegers, E. A., den Heijer, M., and Eskes, T. K. (2000). Hyperhomocysteinemia and recurrent early pregnancy loss: A meta-analysis. Fertil. Steril. 74:1196.
156. Ray, J. G., and Laskin, C. A. (1999). Folic acid and homocysteine metabolic defects and the risk of placental abruption, pre-eclampsia and spontaneous pregnancy loss: A systematic review. Placenta 20:519.
157. Unfried, G., Griesmacher, A., Weismuller, W., Nagele, F., Huber, J. C., and Tempfer, C. B. (2002). The C677T polymorphism of the
158. Gebhardt, G. S., Scholtz, C. L., Hillermann, R., and Odendaal, H. J. (2001). Combined heterozygosity for methylenetetrahydrofolate reductase (MTHFR) mutations C677T and A1298C is associated with abruptio placentae but not with intrauterine growth restriction. Eur. J. Obstet. Gyn. Res. Bull. 97:174.
159. Isotalo, P. A., Wells, G. A., and Donnelly, J. G. (2000). Neonatal and fetal methylenetetrahydrofolate reductase genetic polymorphisms: An examination of C677T and A1298C mutations. Am. J. Hum. Genet. 67:986.
160. Zetterberg, H., Regland, B., Palmer, M., Ricksten, A., Palmqvist, L., Rymo, L., Arvanitis, D. A., Spandidos, D. A., and Blennow, K. (2002). Increased frequency of combined methylenetetrahydrofolate reductase C677T and A1298C mutated alleles in spontaneously aborted embryos. Eur. J. Hum. Genet. 10:113.
161. Grandone, E., Margaglione, M., Colaizzo, D., d'Addedda, M., D'Andrea, G., and Pavone, G. (1998). Methylene tetrahydrofolate reductase (MTHFR) 677T→C mutation and unexplained early pregnancy loss. Thromb. Haemostasis 79:1056.
162. Holmes, Z. R., Regan, L., Chilcott, I., and Cohen, H. (1999). The C677T MTHFR gene mutation is not predictive of risk for recurrent fetal loss. Br. J. Haematol. 105:98.
163. Knapen, M. F. C., Zusterzeel, P. L., and Peters, W. H. (1999). Glutathione and glutathione-related enzymes in reproduction. A review. Eur. J. Obstet. Gyn. Res. Bull. 82:171.
164. Nebert, D. W. (2000). Drug-metabolizing enzymes, polymorphisms and interindividual response to environmental toxicants. Clin. Chem. Lab. Med. 38:857.
165. Wang, X., Chen, D., Niu, T., Wang, Z., Wang, L., Ryan, L. M., Smith, T., Christiani, D. C., Zuckerman, B., and Xu, X. (2000). Genetic susceptibility to benzene and shortened gestation: Evidence of gene-environment interaction. Am. J. Epidemiol. 152:693.
166. Crofts, F., Taioli, E., Trachman, J., Cosma, G. N., Currie, D., Toniolo, P., and Gane, S. J. (1994). Functional significance of different human CYP1A1 genotypes. Carcinogenesis 15:2961.
167. Xu, X., Cho, S.-I., Sammel, M., You, L., Cui, S., Huang, Y., Ma, G., Padungtod, C., Pothier, L., Niu, T., Christiani, D. C., Smith, T., Ryan, L. M., and Wang, L. (1998). Association of petrochemical exposure with spontaneous abortion. Occup. Environ. Med. 55:31.
168. Ungvary, G., and Tatrai, E. (1985). On the embryotoxic effects of benzene and its alkyl derivatives in mice, rats, and rabbits. Arch. Toxicol. Suppl. 8:425.
169. Wang, X., Zuckerman, B., Pearson, C., Kaufman, G., Chen, C., Wang, G., Niu, T., Wise, P. H., Bauchner, H., and Xu, X. (2002). Maternal cigarette smoking, metabolic gene polymorphism, and infant birth weight. J. Am. Med. Assoc. 287:195.
170. Pollack, H., Lantz, P. M., and Frohna, J. G. (2000). Maternal smoking and adverse birth outcomes among singletons and twins. Am J. Public Health 90:395.
171. Pemble, S., Schroeder, K. R., Spencer, S. R., Meyer, D. J., Hallier, E., Bolt, H. M., Ketterer, B., and Taylor, J. B. (1994). Human glutathione S-transferase theta (GSTT1): cDNA cloning and the characterization of a genetic polymorphism. Biochem. J. 300:271.
172. Windham, G. C., Swan, S. H., and Fenster, L. (1992). Parental cigarette smoking and the risk of spontaneous abortion. Am. J. Epidemiol. 135:1394.
173. Zusterzeel, P. L., Nelen, W. L. D., Roelofs, H. J., Peters, W. H. M., Blom, H. J., and Steegers, E. A. (2000). Polymorphisms in biotransformation enzymes and the risk for recurrent pregnancy loss. Mol. Hum. Reprod. 6:474.
174. Zusterzeel, P. L., Visser, W., Peters, W. H., Merkus, H. W., and Nelen, W. L. D. (2000). Polymorphism in the glutathione S-transferase P1 gene and risk for preeclampsia. Obstet. Gynecol. 96:50.
175. Zusterzeel, P. L., Peters, W. H., De Bruyn, M. A. H., Knapen, M. F., Merkus, H. M., and Steegers, E. A. (1999). Glutathione S-transferase isoenzymes in decidua and placenta of preeclamptic pregnancies. Obstet. Gynecol. 94:1033.
176. Rasmussen, S. A., Lammer, E. J., Shaw, G. M., Finnell, R. H., McGehee, R. E. Jr., Gallagher, M., Romitti, P. A., Murray, J. C., and National Birth Defects Prevention Study. (2002). Integration of DNA sample collection into a multi-site birth defects case-control study. Teratology 66:177.